Larvol Delta - A-Multicenter-Study-of-the-Safety-and-Pharmacokinetics-of-Intravenously-Infused-Berubicin-in-Pediatric-Patients-With-Progressive-Refractory-or-Recurrent-High-Grade-Gliomas

berubicin (RTA 744) - CNS Pharma, WPD Pharma

http://clinicaltrials.gov/ct2/show/NCT05082493

Jul 15, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next